7,764 Shares in The Cooper Companies, Inc. $COO Bought by Pallas Capital Advisors LLC

Pallas Capital Advisors LLC bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the second quarter, HoldingsChannel.com reports. The institutional investor bought 7,764 shares of the medical device company’s stock, valued at approximately $557,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. New York Life Investment Management LLC lifted its holdings in shares of Cooper Companies by 0.6% in the fourth quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock valued at $2,241,000 after purchasing an additional 158 shares in the last quarter. Root Financial Partners LLC grew its holdings in shares of Cooper Companies by 104.5% during the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock worth $26,000 after buying an additional 162 shares in the last quarter. Essential Partners LLC raised its position in Cooper Companies by 23.4% in the 1st quarter. Essential Partners LLC now owns 874 shares of the medical device company’s stock valued at $62,000 after buying an additional 166 shares during the last quarter. Allworth Financial LP raised its position in Cooper Companies by 14.1% in the 4th quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock valued at $111,000 after buying an additional 167 shares during the last quarter. Finally, SJS Investment Consulting Inc. lifted its stake in Cooper Companies by 107.5% in the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after acquiring an additional 187 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have weighed in on COO. Citigroup reaffirmed a “neutral” rating and set a $80.00 price target (up from $76.00) on shares of Cooper Companies in a research report on Thursday, August 13th. Needham & Company LLC lowered their price objective on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a report on Friday, June 5th. Piper Sandler set a $86.00 price objective on shares of Cooper Companies and gave the stock an “overweight” rating in a research report on Monday, June 1st. BNP Paribas Exane reduced their target price on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating for the company in a report on Monday, June 8th. Finally, JPMorgan Chase & Co. decreased their target price on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research report on Friday, June 5th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Cooper Companies currently has an average rating of “Hold” and an average price target of $81.64.

Cooper Companies Price Performance

NASDAQ:COO opened at $76.73 on Thursday. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83. The company has a market cap of $14.96 billion, a P/E ratio of 65.03, a P/E/G ratio of 1.98 and a beta of 0.83. The firm’s fifty day moving average price is $71.59 and its two-hundred day moving average price is $71.16. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.10 by $0.11. The company had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. Cooper Companies’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same quarter last year, the company posted $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities analysts expect that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.